Table 4.
DFS | Survival probability (%) | ||||||
---|---|---|---|---|---|---|---|
<2 cycles (n = 216) | ≥2 cycles (n = 15) | <15 days (n = 226) | ≥15 days (n = 5) | ≥85 % RDI (n = 226) | <85 % RDI (n = 5) | Overall % (95 % CI) | |
2 years | 99 | 93 | 98 | 100 | 99 | 80 | 98 (97–100) |
p | 0.126 | 0.765 | 0.001* | ||||
4 years | 91 | 93 | 91 | 100 | 91 | 80 | 91 (87–95) |
p | 0.791 | 0.491 | 0.315 | ||||
5 years | 88 | 93 | 88 | 100 | 88 | 80 | 88 (84–92) |
p | 0.562 | 0.418 | 0.500 | ||||
6 years | 86 | 93 | 86 | 100 | 87 | 80 | 87 (82–91) |
p | 0.473 | 0.375 | 0.563 | ||||
8 years | 84 | 93 | 85 | 100 | 85 | 80 | 84 (79–90) |
p | 0.465 | 0.366 | 0.621 | ||||
10 years | 79 | 93 | 79 | 100 | 80 | 80 | 80 (72–87) |
p | 0.418 | 0.323 | 0.695 |
CI confidence interval, DFS disease-free survival, RDI relative dose intensity
* Statistically significant